Wednesday, October 9, 2013

The Motley Fool: Varian Medical Still The Dominant Player In A Lucrative Market

In some respects, it is a little surprising that Varian Medical (NYSE: VAR  ) is near an all-time high. Revenue and order growth haven't been all that robust lately, rivals like Accuray  (NASDAQ: ARAY  ) and Elekta appear to have some renewed vitality, and reimbursement in the U.S. is still choppy. Then again, we're talking about a company that has more than 50% global installed share in radiation oncology systems, a long record of 20%-plus returns on invested capital, and a well-deserved reputation as a "fast follower" with good technology, strong service, and demonstrated reliability.

Please continue here:

No comments: